Incidence Rate and Prevalence of Systemic Sclerosis and Systemic Sclerosis-Associated Interstitial Lung Disease in Japan: Analysis Using Japanese Claims Databases
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-8652
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Incidence Rate and Prevalence of Systemic Sclerosis and Systemic Sclerosis-Associated Interstitial Lung Disease in Japan: Analysis Using Japanese Claims Databases ; volume:39 ; number:5 ; day:22 ; month:3 ; year:2022 ; pages:2222-2235 ; date:5.2022
Advances in therapy ; 39, Heft 5 (22.3.2022), 2222-2235, 5.2022
- Urheber
-
Kuwana, Masataka
Saito, Aiko
Sakamoto, Wataru
Raabe, Christina
Saito, Kumiko
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12325-022-02078-5
- URN
-
urn:nbn:de:101:1-2022071011121691390479
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kuwana, Masataka
- Saito, Aiko
- Sakamoto, Wataru
- Raabe, Christina
- Saito, Kumiko
- SpringerLink (Online service)
Ähnliche Objekte (12)
Pathogenesis of interstitial lung disease in systemic sclerosis
Interstitial lung disease associated with systemic sclerosis (SSc-ILD)
Metabolomics in systemic sclerosis
Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
Systemic sclerosis-associated interstitial lung disease: How to manage in 2024?
Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease
TFH cells in systemic sclerosis
Erosive Arthropathy in systemic sclerosis
Systemic Sclerosis Association with Malignancy
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease
Macrophages as determinants and regulators of systemic sclerosis-related interstitial lung disease
Interfacial Adipose Tissue in Systemic Sclerosis
Pathogenesis of interstitial lung disease in systemic sclerosis
Interstitial lung disease associated with systemic sclerosis (SSc-ILD)
Metabolomics in systemic sclerosis
Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
Systemic sclerosis-associated interstitial lung disease: How to manage in 2024?
Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease
TFH cells in systemic sclerosis
Erosive Arthropathy in systemic sclerosis
Systemic Sclerosis Association with Malignancy
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease
Macrophages as determinants and regulators of systemic sclerosis-related interstitial lung disease
Interfacial Adipose Tissue in Systemic Sclerosis
Pathogenesis of interstitial lung disease in systemic sclerosis
Interstitial lung disease associated with systemic sclerosis (SSc-ILD)
Metabolomics in systemic sclerosis
Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
Systemic sclerosis-associated interstitial lung disease: How to manage in 2024?
Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease
TFH cells in systemic sclerosis
Erosive Arthropathy in systemic sclerosis
Systemic Sclerosis Association with Malignancy
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease
Macrophages as determinants and regulators of systemic sclerosis-related interstitial lung disease